DM (n = 207) | Non-DM (n = 207) | P-value | |
---|---|---|---|
ALT (U/L) | 315.54 ± 435.76 | 245.23 ± 343.80 | 0.069 |
AST (U/L) | 201.43 ± 272.55 | 172.34 ± 250.14 | 0.259 |
TBIL (μmol/L) | 70.86 ± 83.05 | 57.34 ± 78.99 | 0.090 |
ALB (g/L) | 34.21 ± 10.45 | 35.98 ± 9.57 | 0.073 |
PT (s) | 16.51 ± 6.15 | 15.48 ± 5.94 | 0.083 |
GGT (U/L) | 175.11 ± 162.11 | 121.12 ± 131.38 | < 0.001 |
AFP (ng/mL) | 64.96 ± 115.44 | 56.29 ± 118.27 | 0.451 |
HBeAg positivity | 95 (45.89%) | 66 (31.88%) | 0.003 |
HBV DNA (lg copies/mL) | 5.34 ± 1.59 | 4.78 ± 1.96 | 0.002 |
CREA (μmol/L) | 82.32 ± 49.62 | 69.03 ± 38.21 | 0.002 |
TG (mmol/L) | 1.84 ± 0.93 | 1.22 ± 0.62 | < 0.001 |
Chol (mmol/L) | 4.25 ± 3.06 | 3.84 ± 2.27 | 0.122 |
HDL (mmol/L) | 1.08 ± 0.55 | 1.27 ± 0.69 | 0.002 |
LDL (mmol/L) | 2.34 ± 1.31 | 2.10 ± 1.52 | 0.086 |
FPG (mmol/L) | 8.67 ± 4.20 | 5.11 ± 1.28 | < 0.001 |
HbA1c (%) | 6.81 ± 2.07 | 6.12 ± 1.48 | < 0.001 |
FPI (μU/mL) | 9.42 ± 7.78 | 6.26 ± 3.33 | < 0.001 |
Steatosis | 28 (13.53%) | 10 (4.83%) | < 0.001 |
Cirrhosis | 51 (24.64%) | 34 (16.43%) | 0.040 |
HCC (%) | 12 (5.35%) | 7 (3.21%) | 0.240 |
NA treatmenta | 79 (38.16%) | 73 (35.27%) | 0.541 |
DM treatment | |||
Diet alone | 62 (29.95%) | ||
Metformin | 54 (26.09%) | ||
Sulphonylurea | 19 (9.18%) | ||
Insulin | 72 (34.78%) |